MedTrace Logo

Sevoflurane-Remifentanil Anaesthesia. The Risk of Post Operative Nausea

NCT00452855 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2007-03-29

No results posted yet for this study

Summary

The purpose of this study is to determine whether sevoflurane-remifentanil anaesthesia is similar to propofol-remifentanil anaesthesia concerning post- operative nausea and vomiting.

Conditions

Interventions

PROCEDURE

Sevoflurane-remifentanil anaesthesia

Sponsors & Collaborators

  • Nielsen, Jens OD, M.D.

    collaborator UNKNOWN

  • Central Jutland Regional Hospital

    lead OTHER

Principal Investigators

  • Jens Ole Dich JO Nielsen, MD

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-01-31
Completion
2005-05-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00452855 on ClinicalTrials.gov